Skip to main
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf Inc. has reported robust retail revenues of $255 million, reflecting a quarterly increase of 8.1% and an annual increase of 7.8%, with management expressing optimism about continued growth in the retail segment, particularly in Europe. The company has demonstrated a shift towards sustainable performance by achieving positive free cash flow (FCF) for four consecutive quarters, with an anticipated doubling of FCF to an estimated $205 million in 2025. Additionally, the company is targeting modest expansions in both gross and operating margins, further solidifying the positive outlook as these financial improvements are expected to bolster year-over-year earnings per share (EPS) growth in 2026.

Bears say

Diebold Nixdorf Inc faces a negative outlook due to several fundamental factors impacting its financial performance. Notably, the company's Banking segment has experienced a decline in gross margins, alongside a significant risk associated with technological missteps that could impair revenues and profitability. Additionally, external pressures such as increasing competition, tariff-related costs, and potential disruptions in supply chains further complicate the company’s ability to maintain operational stability and improve working capital.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.